Who invented MPL-TL?
MPL-TL was created by the MPL medical team nearly 2 decades ago, at a time when proteomics and peptide therapeutics were at an early stage of development. The products that resulted were possibly mis-directed, however clinical trials showed that they delivered real and quantifiable benefits in a safe and side-effect free manner. MPL-TL has now moved on and is emerging as an important new active ingredient that delivers needed benefits across a range of common and debilitating disorders and injuries. It is manufactured in a manner that provides extraordinary precision in amino-acid sequencing and this alone may yet prove to be of immense value. MPL-TL’s apparent side-effect-free status and low drug interaction profile may make it ideally suited to a range of conditions and disorders for which topical NSAIDs are contraindicated.
